Annovis Bio, Inc. (ANVS)
NYSE: ANVS · Real-Time Price · USD
1.135
+0.095 (9.13%)
Sep 17, 2026, 3:01 PM EDT - Market open
Annovis Bio Market Cap
Annovis Bio has a market cap or net worth of $48.36 million as of September 17, 2026. Its market cap has increased by 4.71% in one year.
Market Cap
48.36M
Enterprise Value
29.63M
1-Year Change
4.71%
Ranking
Category
Stock Price
$1.14
ChartMarket Cap Chart
Since January 29, 2020, Annovis Bio's market cap has decreased from $62.51M to $48.36M, a decrease of -22.64%. That is a compound annual growth rate of -3.79%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 17, 2026 | 48.36M | -47.27% |
| Dec 31, 2025 | 91.70M | 32.13% |
| Dec 31, 2024 | 69.40M | -63.84% |
| Dec 29, 2023 | 191.90M | 75.03% |
| Dec 30, 2022 | 109.64M | -23.01% |
| Dec 31, 2021 | 142.41M | 174.06% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Jan 29, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Elicio Therapeutics | 52.30M |
| Clene | 51.65M |
| Hyperion DeFi | 51.12M |
| Tevogen | 50.46M |
| Instil Bio | 48.90M |
| Werewolf Therapeutics | 47.63M |
| Immutep | 47.30M |
| Grace Therapeutics | 46.72M |